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Health Impacts of Power-Exporting Plants in Northern Mexico  
Allen Blackman, Santosh Chandru, Alberto Mendoza-Domínguez, and A.G. Russell 
Abstract 
In the past two decades, rapid population and economic growth on the U.S.–Mexico border has 
spurred a dramatic increase in electricity demand. In response, American energy multinationals have built 
power plants just south of the border that export most of their electricity to the United States. This 
development has stirred considerable controversy because these plants effectively skirt U.S. 
environmental air pollution regulations in a severely degraded international airshed. Yet to our 
knowledge, this concern has not been subjected to rigorous scrutiny. This paper uses a suite of air 
dispersion, health impacts, and valuation models to assess the human health damages in the United States 
and Mexico caused by air emissions from two power-exporting plants in Mexicali, Baja California. We 
find that these emissions have limited but nontrivial health impacts, mostly by exacerbating particulate 
pollution in the United States, and we value these damages at more than half a million dollars per year. 
These findings demonstrate that power-exporting plants can have cross-border health effects and bolster 
the case for systematically evaluating their environmental impacts. 
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Health Impacts of Power-Exporting Plants in Northern Mexico  
Allen Blackman, Santosh Chandru, Alberto Mendoza-Domínguez, and A.G. Russell 
1. Introduction 
Rapid population and economic growth on the U.S.–Mexico border during the past two 
decades has spurred a dramatic increase in the region’s demand for electricity, causing 
intermittent excess demand (Romero 2007; Sweedler et al. 2002). In response, American energy 
multinationals have built power plants on the Mexican side of the border that sell most of their 
electricity to the United States. In 2003, two such power-exporting plants began operation three 
miles south of the border near Mexicali, Baja California, and Imperial County, California. 
Owned by Intergen and Sempra Energy and fueled with natural gas imported from the United 
States, the two plants sell three-quarters of their power to the U.S. grid. Various multinational 
companies are reportedly considering building similar power-exporting plants (Powers 2010; 
Barron 2005).  
The Intergen and Sempra plants, and the prospect of more like them, have stirred 
considerable controversy (Carruthers 2007; Spagat 2003; Weiner 2002). Critics contend that they 
will degrade the binational area’s already-poor air quality. By locating just south of the border, 
the plants skirt U.S. federal and state air pollution regulations, including those requiring all new 
facilities in degraded airsheds to offset their emissions (i.e., to pay for more-than-equivalent 
emissions reductions from other sources). Indeed, some argue that a major reason the new power 
plants were built in Mexico was to avoid U.S. environmental restrictions. In response, 
representatives and supporters of the power companies have pointed out that imposing new 
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environmental restrictions on Mexican power-exporting plants would slow investment in new 
generating capacity and raise the cost of energy in the United States. 
These issues have spurred legal and legislative activity as well as popular debate. In 
2002, a coalition of Mexican and U.S. environmentalists brought an (ultimately) unsuccessful 
suit in California state court seeking an injunction barring the plants from exporting to the United 
States (Barron 2005; Tedford 2003). In 2005, the U.S. Congress commissioned an independent 
report on the matter by the U.S. Government Accountability Office (GAO 2005). And in 2010, 
California, alone among the four U.S. states on the Mexico border, passed legislation requiring 
new electricity-generating units in Mexico selling power to the state to comply with its air 
pollution control regulations (California Senate Bill 2037). 
Despite all that activity, the central question of whether the Intergen and Sempra plants 
actually have significant human health impacts has not been subjected to rigorous scientific 
scrutiny. Indeed, the U.S. Government Accountability Office report concludes that ―although 
emissions generated from the Sempra and Intergen plants may contribute to various adverse 
health impacts … the extent of such impacts is unknown‖ (GAO 2005). 
To help fill that gap, this paper uses a suite of air dispersion, health impacts, and 
valuation models to assess the benefits of reducing—and/or offsetting—polluting emissions from 
the Intergen and Sempra power plants in Mexicali and, based on this assessment, to distill 
recommendations for regional energy and environmental policy. Specifically, we address the 
following four questions: What effect do emissions from the Intergen and Sempra plants have on 
ambient concentrations of air pollutants in the Mexicali–Imperial Valley airshed as well as more 
distant downwind areas? What effect do these changes in ambient pollutant concentrations have 
on human morbidity and mortality? What is the economic value of this morbidity and mortality? 
And what are the implications for regional energy and environmental policy? 
Although our analysis focuses on a particular environmental issue in North America, it is 
relevant to air pollution problems on borders between industrialized countries with relatively 
robust environmental regulatory regimes and developing or transitioning countries with weaker 
ones. In such situations, each country may suffer damages from air pollution generated by its 
neighbor. In addition, dirty industries in the industrialized country could, in theory, migrate to 
neighboring ―pollution havens‖ to cut environmental regulatory costs, a phenomenon sometimes 
referred to as a race to the bottom (Fullerton 2006; Spar and Yoffie 2000). Concerns about this 
phenomenon have been voiced in Europe where industrialized countries share airsheds with 
nearby transitioning countries (Lynch 2000; Kaldellis et al. 2007). The electricity sector is of Resources for the Future  Blackman et al. 
3 
particular concern—in 2010, the European members of the Organisation for Economic Co-
operation and Development (OECD) imported 10 percent of their total consumption of 3.5 TWh  
(versus 1 percent for the United States, which consumed a total of 4.2 TWh) (U.S. EIA 2010).      
The remainder of the paper is organized as follows. Section 2 provides information on the 
regulatory context for our own case study and for Europe. Section 3 discusses the history and 
technical characteristics of the Intergen and Sempra plants. Section 4 provides a brief overview 
of our modeling strategy. Section 5 describes our emissions data. Sections 6, 7, and 8 discuss the 
three principal components of our analysis: air quality modeling, health impacts analysis, and 
valuation. Finally, Section 9 summarizes our results and considers policy implications. 
2. Regulatory Context 
This section provides background on environmental regulatory context for transborder 
pollution control in our study countries and, for comparison’s sake, in Europe.   
2.1. The U.S.–Mexico Border 
The federal Clean Air Act (CAA), passed in 1970 and amended in 1977 and 1990, 
provides the foundation for the United States’ decentralized system of air pollution regulation 
(Erickson et al. 2004; KEMA et al. 2007). The CAA establishes broad guidelines for 
environmental management and sets National Ambient Air Quality Standards (NAAQS) for six 
criteria air pollutants—ozone (O3), nitrogen dioxide (NO2), carbon monoxide (CO), particulate 
matter (PM), sulfur dioxide (SO2), and lead (Pb)—as well as guidelines for hazardous air 
pollutants and two O3 precursors, volatile organic compounds (VOCs) and nitrogen dioxides 
(NOx). It assigns to states responsibility for developing and enforcing specific regulations to 
meet NAAQS. They have the option of establishing ambient standards that are more, but not 
less, stringent than those in the CAA. Of the four states on the U.S.–Mexico border, California 
and New Mexico have more stringent ambient standards, while Texas and New Mexico rely on 
federal standards. As mandated under the CAA, two of the principal tools that states use to 
achieve NAAQS are permits and offsets. Granted to individual facilities, permits are licenses to 
emit pollution that typically include sector- or source-specific emissions and/or technology 
standards based on the availability and cost of abatement and pollution prevention technologies. 
In nonattainment areas—those that fail to achieve compliance with NAAQS—sources are 
generally required to offset their emissions by more than 100 percent and to meet stricter 
emissions and technology standards.    Resources for the Future  Blackman et al. 
4 
Mexico has a more centralized system of air pollution regulation (Erickson et al. 2004; 
KEMA et al. 2007). Its framework federal environmental law is the 1988 General Law on 
Ecological Equilibrium and Environmental Protection (Ley General de Equilibrio Ecológico y la 
Protección al Ambiente, LGEEPA), which is complemented by numerous more specific Official 
Mexican Norms (Normas Oficiales Mexicanas, NOMs). The Environmental Ministry (Secretaría 
de Medio Ambiente y Recursos Naturales, SEMARNAT) is responsible for establishing and 
enforcing most environmental regulations, including air pollution regulations in the U.S.–Mexico 
border zone.
1  LGEEPA sets ambient air quality standards that are quite similar to U.S. NAAQS. 
To meet these standards, federal NOMs set sector-specific emissions standards for stationary 
sources of air pollution. In the case of the electricity sector, emissions standards depend on the 
size and type of the generating facility (KEMA et al. 2007; Johnson and Alvarez 2003).  
In general, air pollution control regulation is significantly more stringent on the U.S. side 
of the border, for at least three reasons. First, some ambient air quality standards are more 
stringent. Although Mexican federal ambient standards are generally comparable to U.S. 
NAAQS, as noted above, California’s and New Mexico’s standards are more exacting than 
NAAQS (Erickson et al. 2004). Second, regulations aimed at meeting these ambient air quality 
standards are more stringent. Several U.S. border counties and cities are NAAQS nonattainment 
areas, where new and expanding sources are required to offset their emissions. For example, 
Imperial County, just north of Mexicali, is a nonattainment area for O3 and PM. By contrast, 
offsets are not required in Baja California (Erickson et al. 2004; KEMA et al. 2007).
2 This 
implies that if the Intergen and Sempra plants had been built in U.S. territory north of Mexicali, 
they would have been required to offset their PM, NOx, and VOC emissions. Third, 
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environmental regulatory enforcement is generally stronger in the United States than in Mexico, 
where the Environmental Ministry’s enforcement branch (Procuraduría Federal de Protección 
al Ambiente, PROFEPA) is widely acknowledged to be understaffed and underfunded (Gilbreath 
2003; OECD 2003).    
In principle, international cooperation on air quality management could mitigate 
problems arising from the cross-border disparity in air pollution regulation. Unfortunately, 
however, the legal and institutional basis for such cooperation is limited. With the exception of a 
new California law requiring new power-exporting plants to meet state air pollution regulations, 
U.S. federal and state air pollution control laws and regulations apply only to emissions sources 
located in the United States. The 1983 La Paz Agreement on binational environmental and 
natural resource issues creates only a vague, nonbinding framework for U.S.–Mexican 
cooperation on cross-border air pollution problems. And the environmental side agreements to 
the 1993 North American Free Trade Agreement require each country to enforce only its own 
pollution control laws. Given this legal and institutional context, it is perhaps not surprising that 
actual efforts to control U.S.–Mexico transborder air pollution have been ad hoc, fragmented, 
and weak (GAO 2005; Sánchez-Rodríguez 2002). 
The regulatory framework for cooperation between the United States and Canada on 
transborder air pollution policy is better developed. In 1991, spurred by increasing concern about 
acid rain, the two countries signed a framework for cooperation on transfrontier pollution that 
included specific commitments to reduce sulfur dioxide. They have since negotiated an annex 
focusing on ground-level O3 and implemented binational pollution control projects focusing on 
specific airsheds, namely the Great Lakes and Puget Sound regions (Van Nijnatten 2003; 
Sánchez-Rodríguez et al. 1998).   
2.2. Europe 
On paper, disparities in the stringency of air pollution regulation between industrialized 
and transitioning countries in the European Union (EU) are minimal. To address concerns about 
competitive advantages created by differences in environmental management among member 
countries, the EU has a longstanding policy of ―harmonizing‖ regulations across member sates. 
This policy assumed new importance with the beginning of the process for the accession of East 
and Central European candidate member states (Czech Republic, Estonia, Hungary, Latvia, 
Lithuania, Poland, Slovakia, and Slovenia) to the EU in the early 1990s. To ensure 
harmonization, an EU directive required new members to adopt an entire body of EU 
environmental legislation (Lynch 2000; Milieu Ltd. 2004). Notwithstanding progress on Resources for the Future  Blackman et al. 
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harmonization, however, observers have raised concerns about persistent differences in 
monitoring and enforcement in Central and Eastern European candidate member states (Lynch 
2000; Jacoby 1999).   
In addition to harmonizing regulations, EU countries also have established a legal and 
institutional framework for managing transborder pollution. In 1979, the countries signed the 
Convention on Long Range Transboundary Air Pollution, which established a framework for 
subsequent specific agreements, including the 1985 Sulfur Protocol committing all signatories to 
reduce sulfur dioxide emissions by 30 percent from a 1980 baseline over eight years; the 1988 
Nitrogen Protocol, which committed signatories to maintain nitrogen oxides below 1987 levels 
until 1994; and a 1999 second Sulfur Protocol, which committed all signatories—including eight 
new East and Central European candidate members—to binding country-specific emissions 
reductions (Kaldellis et al. 2007; ApSimon and Warren 1996).  
3. Power Plants 
The Intergen and Sempra power plants are located in Mexicali, Baja California, 
approximately three miles south of the U.S.–Mexico border. Mexicali’s U.S. sister city is 
Calexico, Imperial County, California (Figure 1). Both plants are combined-cycle natural gas–
fired facilities, and both use fuel imported from the United States through a pipeline constructed 
by Sempra. Construction of the Intergen and Sempra plants, along with associated transmission 
lines, began in 2001, and both plants began operating in July 2003.  
By all accounts, excess demand for electricity in California in 2000 and 2001 spurred 
Intergen’s and Sempra’s investment in the plants. Most analysts also agree that Intergen’s and 
Sempra’s decisions to build in Mexico were mainly driven by its shorter wait-times for 
regulatory permits (six months versus two years in California) and lower capital and labor costs. 
That said, most observers also agree that less stringent environmental regulation in Mexico may 
have played a role (Barron 2005; Tedford 2003). 
The only international environmental regulatory hurdle that Intergen and Sempra plants 
in Mexicali faced was a U.S. regulation requiring foreign power plants using international 
transmission lines to the United States to obtain a presidential permit, which in turn is 
conditional on a U.S. Department of Energy (DOE) environmental impact assessment (EIA). 
Based on a 2001 EIA (which was refined in 2004), both plants were granted presidential permits 
(DOE 2004). However, as noted above, the EIA lacked a rigorous assessment of the health 
impacts of the power plant emissions, and partly as a result, it was contested in federal court by Resources for the Future  Blackman et al. 
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local environmental advocacy groups (Barron 2005; GAO 2005).  
 
Figure 1. Location of Integen and Sempra Power Plants in Mexicali, Baja California and 
Air Quality Modeling Domain (36-km, 12-km, and 4-km grids) 
 
The Intergen plant is known as the La Rosita Power Complex (LRPC). It houses two 
units. The first is owned by Energía Azteca X, S. de R.L. de C.V. (EAX), an Intergen subsidiary. 
It comprises three Seimens-Westinghouse Model W501F 160-MW combustion turbines and one 
Alstrom 270-MW steam turbine. Collectively, the unit has 750 MW of capacity. The second unit 
is owned by Energía de Baja California S. de R.L. de C.V. (EBX), a Mexican company. It 
comprises one Seimens-Westinghouse Model W501F 160-MW combustion turbine and one 
Alstrom 150-MW steam turbine. Collectively, this unit has a capacity of 310 MW.  
 Two-thirds of the power generated by EAX—all of the power from two of its three 
combustion turbines and two-thirds of the power from its steam turbine (2X160 MW+180MW = 
500 MW)—is sold to Mexico, and the rest (160 MW + 90 MW = 250 MW) is exported to the 
United States. All of the EBC 310-MW capacity is exported. Hence, overall, the Intergen plant 
has a capacity of 1060 MW, of which 560 MW is devoted to exports and 500 MW to domestic 
production.  Resources for the Future  Blackman et al. 
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The Intergen plant does not use oxidizing catalysts or any other abatement method to 
reduce CO emissions. When the plant began operating in 2003, only one of its four combustion 
turbines—that in the EBC unit—employed selective catalytic reduction (SCR) to reduce 
emissions of NOx.
3 However, the three combustion turbines in the EAX unit were subsequently 
retrofitted with SCR (turbine 1 in March 2005, turbine 2 in April 2005, and turbine 3 in March 
2004). Hence, since April 2005, all four combustion turbines in the Intergen plant have 
employed SCR.  
The Sempra plant is owned by Termoeléctrica de Mexicali (TDM), a Sempra subsidiary. 
It consists of two General Electric Model 7FA 170-MW combustion turbines and one Alstrom 
310-MW steam turbine. The plant thus has 650 MW of generating capacity. One hundred percent 
of the plant’s power output is exported to the United States. Both combustion turbines in Sempra 
plant were built with SCR and oxidizing catalyst units to reduce NOx and CO emissions.  
4. Modeling Overview  
Our analysis of the effects of the Intergen and Sempra plants’ pollution on human health 
has three broad components, which are described in detail in Sections 6, 7, and 8 (Figure 2). The 
first is air quality modeling, for which we use the Models-3 system, a three-dimensional 
chemical-transport air quality modeling system. Inputs for this component include data on 
polluting emissions from the Intergen and Sempra plants, polluting emissions from other sources 
in our modeling domain, and meteorology, topography, and land use in this domain. The output 
from our air quality model is hourly spatial data on air quality for two multiday modeling 
episodes.  
 
                                                 
3 SCR units reduce NOx by exposing combustion emissions to a spray of ammonia in the presence of a catalyst, 
typically platinum. The NOx reacts with the ammonia to produce nitrogen and water vapor. Resources for the Future  Blackman et al. 
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Figure 2. Overview of Data and Models 
 
The second component of our analysis is health impacts modeling, for which we use the 
Tracking and Analysis Framework (TAF), an integrated tool for benefit-cost analysis. TAF 
estimates health impacts for two pollutants: O3 and particulate matter smaller than 2.5 microns 
(PM2.5). In addition to the output from our air quality model (spatial data on air quality), inputs 
for the TAF health impacts model include spatial data on demography in our modeling domain 
and baseline data on health status. The outputs from this model are estimates of the number of 
cases of mortality and morbidity attributable to Intergen and Sempra pollution, broken down by 
plant (Intergen and Sempra), country (Mexico and the United States), and pollutant (O3 and 
PM).  Resources for the Future  Blackman et al. 
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The final component of our analysis is valuation modeling, for which we again use TAF. 
This component assigns monetary values to our estimates of the incidence of various health 
effects. 
5. Emissions 
Our estimates of most polluting emissions from the Intergen and Sempra plants—
specifically, NO2, CO, particulates matter smaller than 10 microns (PM10), ammonia (NH3), 
and VOCs—are based on 2003 and 2004 third-party tests reported in GAO (2005), which 
characterizes these estimates as the most accurate emissions data available. For some pollutants 
(PM10 and VOCs), GAO (2005) reports hourly emissions, and for others (NOx, CO, and NH3), 
it reports stack gas concentrations. We convert the hourly emissions to annual emissions 
assuming the plants operate at capacity 64 percent of all available hours, the average capacity 
factor for recently built U.S. combined-cycle natural gas plants (Paul et al. 2009). We convert the 
concentration data to annual emissions using measurements of actual fuel consumption from 
DOE (2004, Table G1) and assuming again the plants operate at capacity 64 percent of all 
available hours (see Appendix 1). Finally, we estimate emissions of particulate matter smaller 
than 2.5 microns (PM2.5) from PM10 emissions (following U.S. EPA 1997) and SO2 emissions 
from DOE (2004, Table G1). Table 1 reports our results.  Resources for the Future  Blackman et al. 
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Table 1. Intergen and Sempra Plant Mass Emissions Rates (short tons/year*) 
Pollutant  Intergen
a  Sempra 
NOx
b  327.08  155.95 
CO
b  63.55  0.00 
PM10
c  84.21  89.01 
NH3
b  63.53  11.24 
VOCs
c  9.54  0.00 
PM2.5
d  84.21  89.01 
SO2
e  12.47  6.99 
NOx = nitrogen oxides; CO = carbon monoxide; PM10 = particulate matter smaller 
than 10 microns; NH3 = ammonia; VOCs = volatile organic compounds; PM2.5 = 
particulate matter smaller than 2.5 microns; SO2 = sulfur dioxide. 
*1 short ton = 0.907 metric tons. 
aAssumes all Intergen plant turbines have selective catalytic reduction (SCR) units. 
SCR was installed on the Energía de Baja California (EBC) unit when it was built 
but was added to the Energía Azteca X (EAX) after construction. It was added to 
EAX Turbine 3 prior to the third-party tests reported in GAO (2005), and to EAX 
turbine 1 and  2 after these tests. SCR affects emissions of NOx and NH3. Therefore, 
we assume that NOx and NH3 emissions from EAX turbines 1 and 2 are the same as 
emissions from EAX turbine 3. 
bEstimated from concentration in ppm assuming 65% capacity factor; see Appendix 
1. 
cEstimated from emissions in pounds per hour, which are converted to short tons per 
year assuming a 65% capacity utilization factor. 
dEstimated from PM10 following (U.S. EPA 1997). 
eEstimated from DOE (2004, Table G1). 
 
Sources: GAO (2005); DOE (2004); own calculations. 
6. Air Quality Modeling 
To gauge the effect of emissions from the Intergen and Sempra plants on ambient air 
pollution concentrations in and around our study area, we applied an extended version of the 
Models-3 system, a three-dimensional chemical-transport air quality modeling system, to the 
Mexicali–Imperial Valley (Byun et al. 2005; U.S. EPA 1999). This application is described in 
detail in Mendoza-Dominguez et al. (2007), and its use in generating the results presented in this 
paper is described in Chandru (2008). Drawn from Chandru (2008), this section offers a brief 
overview of the principal steps involved in applying the Models-3 system and summarizes the 
main results.  
6.1. Modeling Domain 
We applied the Models-3 system using nested grids covering the border region (Figure 
1). Vertically, we used 15 layers—that is, 15 slices of atmosphere of variable thickness. The Resources for the Future  Blackman et al. 
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lowest layer, the air people typically breathe, is 18 meters thick. The top of the modeling domain 
is 15 km above ground. Horizontally, at the most coarse resolution, we used 36-km grids. We 
used 12-km and 4-km grids for the Mexicali–Imperial Valley area. The coarse grid system 
allows relatively rapid simulation to set appropriate boundary conditions for the finer grid. 
6.2. Application of Models-3 System 
6.2.1. Episode Selection 
The Models-3 system is quite computationally intensive and therefore simulates changes 
in air quality for multiday episodes within a defined year or years, rather than for an entire year. 
Following Boylan et al. (2005), Kuebler et al. (2002), and others, we used classification and 
regression tree (CART) analysis to select the days for these episodes. The objective was to select 
multiday periods that represent a variety of meteorological conditions that generate high air 
pollution levels. Also known as binary recursive partitioning, CART is a nonparametric 
statistical technique used for data classification and predictive modeling (Brieman et al. 1984). It 
generates a decision tree that defines the relationship between a categorical dependent variable 
and a set of independent variables. In our case, days of the years are observations, the categorical 
dependent variable is a series of ranges of average daily pollutant concentrations, and the 
independent variables are average daily meteorological conditions, such as temperature and wind 
speed. (As discussed in Section 7.1.1, a decision tree generated by CART also is used in our 
health impacts modeling to determine how representative each episode-day is in terms of 
meteorological conditions associated with high concentrations.) The meteorological data used for 
the CART analysis were collected from three air quality monitoring stations close to the border 
region in Calexico for 2001 and 2002. They include maximum daily temperature, mean wind 
direction, mean wind velocity, mean solar radiation, and maximum and minimum humidity. 
Based on the CART analysis, two episodes were selected: one, August 18–27, 2001, was 
intended to capture high O3 in summer, and a second, January 6–15, 2002, high CO and PM in 
winter.   
6.2.2. Mesoscale Meteorological Model 
We used a fifth-generation Mesoscale Meteorological Model (MM5) to simulate 
atmospheric circulation (Seaman 2000). It consists of several auxiliary programs: TERRAIN 
horizontally interpolates and generates terrain, land-use, and map-scale data; REGRID uses 
gridded meteorological data to forecast pressure levels and interpolates these to the horizontal 
grid and map projection defined by TERRAIN; LITTLE_R develops gridded pressure-level Resources for the Future  Blackman et al. 
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meteorological data (wind, temperature, relative humidity, sea level pressure) used as a first 
guess; INTERPF transforms data from the above programs to a mesoscale model and performs 
vertical interpolation; MM5 uses meteorological data generated by other auxiliary programs to 
predict weather over time; and the Meteorology-Chemistry Interface Processor links MM5 
output to other parts of Models-3 framework.  
6.2.3. Sparse Matrix Operator Kernel Emissions Module 
We used the Sparse Matrix Operator Kernel Emissions Module (SMOKE) to generate 
spatially gridded emissions files (Houyoux and Vukovich 1999). The input data for SMOKE are 
raw emissions inventories comprising total annual emissions for area and point sources and total 
monthly emissions for mobile sources. The output data are hourly emissions for each grid cell 
and pollutant. SMOKE includes both criteria and toxic pollutants and accommodates both 
biogenic and nonbiogenic (area, point, and mobile) emissions sources. The data input into 
SMOKE were drawn from the 2001 U.S. National Emissions Inventory and the 1999 Big Bend 
Regional Aerosol and Visibility Observational Study and 1999 Mexican National Emissions 
Inventory of the six Mexican border states.  
6.2.4. Community Multiscale Air Quality Model 
The Community Multiscale Air Quality (CMAQ) model with the decoupled direct method 
represents the state-of-the-science for modeling air quality (Byun et al. 2005; Napelenok et al. 
2006). It consists of several processors: the initial conditions processor provides concentration 
data for pollutants for the first hour of the simulation; a boundary conditions processor creates 
concentration data for the ends of the domain grids; a photolysis rate processor calculates photo-
dissociation reaction rates; and a chemical-transport model processor simulates relevant 
atmospheric chemistry and transport processes.  
Using the CMAQ model to estimate the effect of the Intergen and Sempra plants on 
ambient concentrations of O3 and PM2.5—the two pollutants in our TAF health models—is 
challenging, for several reasons. First, O3 and some PM2.5 are generated by chemical reactions 
involving precursor pollutants, such as NOx and VOCs, in processes that are complex and 
nonlinear. Second, both are regional pollutants affected by processes spanning large areas. 
Finally, natural gas–fired power plants are much cleaner than coal-fired plants and emit 
relatively low levels of pollution.  
Two general strategies are available for estimating the effect of the Intergen and Sempra 
plants on ambient concentrations. The first is the brute force method, which entails simulating air Resources for the Future  Blackman et al. 
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quality first without the plants (i.e., determining a baseline) and then with the plants, and 
comparing the two simulations over space. However, this approach tends to be reasonably 
accurate only for large-scale emission changes. The second strategy is to use the decoupled 
direct method, which calculates the derivative of pollutant concentrations with respect to changes 
in emissions directly from the governing equations of the air quality model and then linearly 
extrapolates the derivative using the specific emission change associated with the power plants 
(Cohan et al. 2005). We use this second strategy because the emissions from the Intergen and 
Sempra power plants are relatively small and locally concentrated and would not be accurately 
captured using the brute force approach (Cohan et al. 2005). 
The CMAQ model does not explicitly account for uncertainty in the relationships 
between model inputs (emissions, meteorology, topography, land use) and spatial air quality data 
by, for example, predicting distributions of air quality results instead of deterministic values. 
That said, the CMAQ model performance in our study area was evaluated by comparing 
predicted values of ambient O3 with actual O3 measurements for baseline scenarios. These 
evaluations indicated that the model preformed quite well (Mendoza-Domínguez et al. 2011). 
6.3. Model Results 
This section describes the Models-3 system’s estimates of the effect of the Intergen and 
Sempra plants on concentrations of O3 and PM2.5 during the two 10-day study episodes: August 
18–27, 2001, a summer peak O3 period, and January 6–15, 2002, a winter peak PM 2.5 period. 
6.3.1. Intergen Plant 
Ozone. During the January episode, the Intergen plant’s effect on ambient O3 
concentrations is negligible. During the August episode, however, the Intergen plant’s peak O3 
effect is 8×10
–1 ppbv. During this episode, prevailing local winds blow northwest while synoptic 
winds tend to have a northeasterly direction (Vanoye and Mendoza-Domínguez 2009). As a 
result, O3 plumes from the Intergen plant affect Calexico, just north of Mexicali, and the border 
region between Mexico and Arizona (Figures 3a and 3b). O3 plumes are transported into 
Arizona, and plumes of up to 3×10
–2 ppbv affect Grand Canyon National Park, east of Las 
Vegas. Plumes also move southeast into Sonora, Mexico. Resources for the Future  Blackman et al. 
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Figures 3a, 3b, 3c. Simulated Plumes from Intergen Plant: Ozone (O3) on August 26, 2001 and Particulate Matter Smaller 
than 2.5 microns (PM2.5) on January 9, 2002 
 
  (a)  (b)  (c) Resources for the Future  Blackman et al. 
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PM2.5. The Intergen plant’s peak effect on PM2.5 occurs during the January episode, 
when plume concentrations reach 2.0 ×10
–1 g/m
3 near the power plant (Figure 3c). A PM2.5 
plume from the Intergen plant moves both southeast into Baja California and northwest into 
southern California.  
6.3.2. Sempra Plant 
Ozone. During the January episode, the Sempra plant’s effect on ambient O3 
concentrations is negligible. During the August episode, however, its peak O3 effect is 2.9×10
–1 
ppbv over the Mexicali-Calexico border region (Figure 4a). Some plumes are also transported to 
California and Arizona (Figure 4b).  




Figures 4a, 4b, 4c. Simulated Plumes from Sempra plant: Ozone (O3) on August 25, 2001 and Particulate Matter Smaller 
than 2.5 microns (PM2.5) on January 9, 2002 
 
  (a)  (b)  (c) 
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PM2.5.The Sempra plant’s peak effect on PM2.5 occurs during the January episode, 
when concentrations reach 2.1×10
–1 g/m
3south of Mexicali (Figure 4c). Plumes from the plant 
also are transported to California. 
7. Health Impacts: Incidence 
7.1. Model 
Our health impacts incidence analysis estimates the number of cases of human morbidity 
and mortality caused by exposure to O3 and PM2.5 attributable to the Intergen and Sempra 
plants. This analysis entailed three steps, each of which is described below in separate 
subsection.  
7.1.1 CART Analysis: Average Annual Pollutant Concentrations  
The first step in generating estimates of health impacts from Intergen and Sempra air 
pollution was to convert the output of the air quality models into the format required by our 
health model (Figure 2). As discussed above, our air quality models generate estimates of hourly 
concentrations of O3 and PM2.5 during two 10-day episodes (August 18–27, 2001, and January 
6–15, 2002). However, to estimate health impacts, we require data on annual changes in human 
exposure to pollutants, which in turn requires data on average annual concentrations of O3 and 
PM2.5. Following Palmer et al. (2007), Boylan et al. (2005), and others, we converted changes in 
daily concentrations to changes in annual concentrations using a weighted average. A CART 
analysis was used to construct the weights. As discussed in Section 6.2.1, CART analysis is a 
nonparametric statistical technique that essentially determines the extent to which each episode-
day is representative of meteorological conditions associated with high O3 and PM2.5 
concentrations. We used 14 of our 20 episode-days to calculate weighted averages, omitting the 
first three days of each period because they are a stabilizing period.  
7.1.2. Demographic Model: Average Annual Human Exposure 
The second step in generating estimates of health impacts from Intergen and Sempra air 
pollution was to calculate the number of people in different age groups exposed to this pollution. 
To do this, we obtained year 2000 census data at the level of areas geoestadíticas básicas for 
two Mexican border states (Baja California and Sonora) and census tracts for three U.S. border 
states (Arizona, California, and Nevada). Figure 5 presents the results of this exercise. Next, we 
used geographic information system software to overlay these demographic data onto gridded 
data on changes in average annual concentrations of O3 and PM2.5 from our air quality and Resources for the Future  Blackman et al. 
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CART models, and to calculate the number of people in various age groups exposed to this 
pollution.  









7.1.3. Tracking and Analysis Framework: Incidence of Human Mortality and Morbidity 
The final step in generating estimates of health impacts from Intergen and Sempra air 
pollution was to use our estimates of human exposure in combination with concentration 
response (CR) coefficients drawn from the epidemiological literature on air pollution to estimate 
incidence of human morbidity and mortality. To do this, we used the 2006 version of the TAF, 
an integrated tool for benefit-cost analysis created to evaluate proposals for abating sulfur 
dioxide emissions (which cause acid precipitation) and later updated and used in numerous other 
studies (Bloyd et al. 1996; Lankton 2006; Palmer et al. 2007). We use TAF to model incidence 
rates for 15 health endpoints: mortality from O3, mortality from PM2.5, 2 types of morbidity 
from O3, and 11 types of morbidity from PM2.5 (Table 2).   
 Resources for the Future  Blackman et al. 
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Table 2. Health Effects of Ozone (O3) and Particulate Matter Smaller than 2.5 Microns 
(PM2.5) Exposure Modeled by TAF, by Age Group and Method Used to Value Effects 
Linked to O3 exposure  Age group  Valuation method 




Asthma emergency room visits  All ages  COI 
Short-term mortality  All ages  WTP 
Linked to PM2.5 exposure     
Mortality  < 1 
30 + 
WTP 
Chronic bronchitis  27 +  WTP 
Nonfatal heart attacks  18 +  COI 
Respiratory hospital admissions  All ages  COI 




Asthma emergency room visits  All ages  COI 
Acute bronchitis in children  8–12  WTP 
Upper respiratory symptoms in children  9–17  WTP 
Lower respiratory symptoms in children  7–14  WTP 
Asthma exacerbation  5–17  WTP 
Work loss days  18–64  COI 
Minor restricted activity days   18–64  WTP 
COI = cost of illness; WTP = willingness to pay. 
  
Of the various types of morbidity included in the TAF model, most are self-explanatory, 
but a few require clarification. A minor restricted activity day, as defined by the U.S. Department 
of Health and Human Services in its Health Interview Survey, refers to restrictions on daily 
activities that are less severe than spending the day in bed or missing work or school, but more 
serious than sneezing or coughing that does not restrict activity. Short-term mortality refers to 
premature mortality predicted by econometric studies relating daily mortality rates in a given city 
to daily measures of air pollution and other variables, such as temperature. Asthma exacerbation 
refers to an episode of coughing, wheezing, or shortness of breath caused by asthma. 
To estimate incidence rates for the 15 health endpoints in Table 2, TAF relies on a set of 
CR coefficient distributions, drawn from the epidemiological literature, that indicate the 
marginal probability of a range of cases of mortality and morbidity due to a change in exposure 
to O3 and PM2.5 given a baseline rate of mortality or morbidity. For many of these health 
endpoints, TAF uses a weighted average of two or more CR distributions reported in the Resources for the Future  Blackman et al. 
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literature.
4 Most baseline incidence rates were obtained from the BenMap model used by U.S. 
EPA for regulatory analyses (U.S. EPA 2011). Appendix 2 provides details on the TAF CR 
functions.   
TAF uses a Monte Carlo numerical simulation procedure to generate 95 percent 
confidence intervals around mean predictions of the incidence of each health endpoint. For each 
heath endpoint, TAF randomly chooses values from the probability distribution for each CR 
coefficient and then calculates an incidence rate based on the chosen values. It repeats this 
process hundreds of times to generate a distribution of estimated incidence rates, which is used to 
calculate 95 percent confidence intervals. Note these confidence intervals do not account for 
uncertainty in our air quality modeling and therefore are likely understate the true variability in 
our results.  
A complication arises because our study domain spans two countries in which 
epidemiological responses to air pollution may differ because of socioeconomic and 
environmental conditions, baseline health status, health care quality, and other factors. Ideally, 
we would use CR distributions drawn from epidemiological studies in the United States to 
estimate U.S. health impacts, and CR distributions from Mexico to estimate Mexican health 
impacts. However, we have used the TAF module, based mostly on U.S. epidemiological 
studies, for both countries, for several reasons. First, far fewer epidemiological studies are 
available for Mexico than for the United States, so even if we attempted to use separate CR 
distributions for Mexico, we still would be forced to use many TAF CR distributions to fill gaps. 
Second, using different CR distributions for the two countries would make it difficult to 
determine whether disparities in health impacts arose from differences in exposure or differences 
in CR distributions. Third, as discussed below, exposure to Intergen and Sempra power plant 
pollution is far greater in the United States, so it is arguably less important to account for 
differences in epidemiological responses in Mexico. And finally, given the resources available 
for this study, constructing a different health impacts model for each country was simply not 
feasible.  
 
                                                 
4 The weights (which are the default weights in TAF) mimic the methods that the U.S. Environmental Protection 
Agency (EPA) used in its analysis of the proposed Interstate Air Quality Rule and Nonroad Diesel Rule. Resources for the Future  Blackman et al. 
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7.2. Results 
Table 3 reports TAF model estimates of the annual  incidence of human mortality and 
morbidity due to O3 and PM2.5 pollution attributable to Intergen and Sempra plants. A few 
broad trends are apparent. First, overall, health impacts from both plants are quite limited. Of the 
15 health endpoints included in the TAF model, mean predicted annual incidence is zero for 5, 
and less than one for 13. Second, O3 in particular has negligible effects. Even at the low end of 
the 95% confidence interval, predicted incidence is zero for all ozone health endpoints. Third, 
the incidence of less serious health endpoints, such as work loss days and minor restricted 
activity days, due to PM2.5 is not insignificant. For example, the mean estimate for all minor 
restricted activity days is 366 cases per year, and the mean estimate for all work loss days is 65 
per year. Finally, most health effects from the two plants occur in the United States. The average 
ratio of (nonzero) health effects in the United States versus Mexico is 2.3. 
What explains these results? The modest overall health effects stem from the fact that, as 
GAO (2005) emphasizes, the Intergen and Sempra plants’ emissions are low relative to coal-
fired plants and older gas-fired plants. In addition, most of the areas covered by the Intergen and 
Sempra plants’ emissions plumes are sparsely populated (Figures 3, 4, and 5). Three factors 
explain our finding that effects from NOx are completely negligible: (i) as just noted, the plants 
are relatively clean and the downwind areas are sparsely populated; (ii) in contrast to the PM2.5 
health endpoints, all the NOx health endpoints are relatively serious, involving either hospital 
visits or mortality; and (iii) titration (a phenomenon in which NOx ―scavenges,‖ or reduces, O3 
during certain times of the day) offsets the contribution of NOx to the formation of O3 
(Mendoza-Domínguez et al. 2011; Seinfeld and Pandis 1997; DOE 2004). Finally, our finding 
that PM2.5 from Intergen and Sempra has nontrivial health effects, most of which occur in the 
United States, stems from the fact that the plants’ PM2.5 plumes are transported northwest into 
inhabited parts of southern California.  Resources for the Future  Blackman et al. 
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Table 3. Annual Cases of Human Mortality and Morbidity from Pollution Generated by Intergen and Sempra Plants, 
by Pollutant and Country: Mean Estimates and 95% Confidence Intervals 
Pollutant  Health endpoint      Intergen          Sempra     
    United States    Mexico    United States    Mexico   
    Low  Mean  High  Low  Mean  High  Low  Mean  High  Low  Mean  High 
O3 
Respiratory hospital admissions, ages 65+  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00 
Respiratory hospital admissions, ages < 2  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00 
Asthma emergency room visits  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00 
Short-term mortality  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00 
PM2.5 
Mortality, ages < 1  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00 
Mortality, ages 30+  0.01  0.04  0.08  -0.01  0.02  0.04  0.01  0.03  0.05  -0.01  0.02  0.03 
Chronic bronchitis, ages 18+  0.03  0.17  0.34  -0.01  0.03  0.06  0.02  0.11  0.23  0.00  0.02  0.04 
Nonfatal heart attacks, ages 18+  0.01  0.09  0.16  0.01  0.07  0.12  0.01  0.06  0.11  0.01  0.05  0.08 
Respiratory hospital admissions  -0.01  0.03  0.05  0.01  0.03  0.06  -0.01  0.02  0.03  0.00  0.02  0.04 
Cardiovascular hospital admissions, ages 18–64  0.00  0.01  0.01  0.00  0.01  0.01  0.00  0.00  0.01  0.00  0.00  0.01 
Cardiovascular hospital admissions, ages 65+  0.01  0.01  0.02  0.00  0.00  0.01  0.00  0.01  0.02  0.00  0.00  0.00 
Asthma emergency room visits, ages < 18  0.01  0.02  0.03  0.02  0.04  0.06  0.01  0.02  0.02  0.01  0.02  0.04 
Acute bronchitis in children, ages 8–12  -0.04  0.11  0.26  -0.01  0.16  0.35  -0.03  0.08  0.18  0.00  0.11  0.24 
Upper resp. symptoms in children, ages 9–17  1.28  12.02  28.07  0.45  6.43  13.38  0.87  8.19  19.12  0.31  4.44  9.24 
Lower resp. symptoms in children, ages 7–14  2.25  4.93  9.65  0.56  1.70  2.71  1.53  3.36  6.57  0.39  1.18  1.89 
Asthma exacerbations, ages 6–18  0.75  4.88  7.34  0.91  1.80  2.76  0.51  3.32  5.00  0.63  1.25  1.92 
Work loss days, ages 18–64  27.15  30.54  34.88  6.82  7.89  9.68  18.49  20.79  23.75  4.70  5.43  6.66 
Minor restricted activity days, ages 18–64  142.19  173.28  211.58  37.21  44.68  54.01  96.81  117.98  144.06  25.61  30.76  37.17 Resources for the Future  Blackman et al. 
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8. Health Impacts: Valuation 
8.1. Model 
We use the valuation module of TAF to assign monetary values to the estimates 
of the incidence of human mortality and morbidity discussed above (Figure 3). This 
module consists of valuation functions drawn from the environmental and health 
economics literatures.  For details on the TAF valuation functions, see Appendix 2. As in 
the health effects incidence module of TAF, several functions are sometimes used in 
conjunction with a single health impact. In such cases, estimates for each are a weighted 
average of estimates from each valuation function.
5  Also, the valuation module of TAF, 
like the health impacts module, uses Monte Carlo techniques to generate 95 percent 
confidence intervals around mean value estimates.  
The TAF valuation module uses two types of valuation functions: cost of illness 
(COI) and willingness to pay (WTP) (Table 2). COI functions value health impacts by 
estimating the pecuniary and nonpecuniary expenses paid by individuals and insurance 
companies for illness, including the payments for actual health care, lost wages, and 
opportunity costs of time. WTP functions aim to capture the maximum amount 
individuals would be willing to pay to avoid illness or the risk of premature death. WTP 
is estimated by revealed- or stated-preference methods. Reveled-preference methods 
tease out individuals’ WTP from market behavior affected by health concerns. For 
example, some revealed-preference studies estimate WTP by examining the correlation 
between wages and occupational safety hazards. Stated-preference methods involve 
developing and administering surveys designed to elicit individuals’ true preferences for 
avoiding health risks (Freeman 1993).  
Not surprisingly, monetary values assigned to mortality, known as the value of a 
statistical life (VSL), are generally an order of magnitude greater than those assigned to 
morbidity. We use the VSL estimate from Mrozek and Taylor (2002), which has a central 
value of $2.324 million. This estimate is quite conservative: it is at the low end of the 
values used in benefit-cost analysis. For example, 2009 U.S. EPA rules mandate that 
                                                 
5 As in the case of the health impacts incidence analysis, the weights (which are the default weights in 
TAF) mimic the methods EPA used in its analysis of the proposed Interstate Air Quality Rule and Nonroad 
Diesel Rule. Resources for the Future  Blackman et al. 
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benefit-cost analyses use a VSL of $7.9 million, and 2009 U.S. Department of 
Transportation rules mandate a VSL of $6.0 million (Copeland 2010).  
Like the incidence of mortality and morbidity, the values of mortality and 
morbidity probably differ between the two countries, in this case because of differing 
perceptions of mortality risk and differing types and costs of medical care, among other 
factors. Ideally, we would use Mexican COI and WTP parameters to estimate the value of 
Mexican health damages. However, to estimate values of health impacts in Mexico would 
require collecting COI and WTP data that are comparable to those for the United States, 
in terms of both the type and the severity of illness. Unfortunately, to our knowledge, 
comparable data are not available from secondary sources for Mexico, and collecting 
them from primary sources is beyond the scope of our effort. Hence, we use the U.S. COI 
and WTP parameters in TAF to value Mexican mortality and morbidity. This is arguably 
acceptable in our study because Mexican health damages are minor compared with those 
in the United States. Also, using the same valuation functions avoids the difficult issue of 
valuing health impacts differently for two populations that are geographically, culturally, 
and economically close. That said, studies typically assign lower values to health impacts 
in developing countries (Alberini et al. 1997; Loehman et al. 1979). Therefore, our 
estimates of the value of Mexican morbidity and mortality are likely biased upward. 
8.2. Results  
The patterns of the valuation results mirror those described in the above 
discussion of health impacts incidence: although overall health effects are limited, 
particularly from O3, health effects from PM2.5 are nontrivial, and most health effects 
are in the United States, not Mexico (Table 4). The valuation models simply put numbers 
to these findings. Our mean estimates of the annual value of health damages attributable 
to Intergen emissions are $230,000 in the United States and $104,000 in Mexico. Mean 
estimates of annual damages attributable to Sempra emission are $160,000 in the United 
States and $72,000 in Mexico. The total value of annual health damages attributable to 
both plants is $566,000.
6
                                                 
6 The $566,000 figure is the sum of the total mean values of the Intergen plant’s health damages in the 
United States ($230,000) and in Mexico ($104,000) and the Sempra plant’s health damages in the United 
States ($160,000) and in Mexico ($72,000). All these values are in the bottom row of Table 4. Resources for the Future  Blackman et al. 
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Table 4. Annual Value of Human Mortality and Morbidity from Pollution Generated by Intergen and Sempra Plants, 
by Pollutant and Country: Mean Estimates and 95% Confidence Intervals (thousands of year-2000 US$) 
Pollutant  Health endpoint      Intergen          Sempra     
      U.S.      Mexico      U.S.      Mexico   
    Low  Mean  High  Low  Mean  High  Low  Mean  High  Low  Mean  High 
O3 
Respiratory hospital admissions, ages 65+  1  4  7  0  0  0  0  2  3  0  0  0 
Respiratory hospital admissions, ages < 2  1  3  5  0  1  2  0  1  2  0  0  1 
Asthma emergency room visits  0  0  0  0  0  0  0  0  0  0  0  0 
Short-term mortality  6  10  16  1  2  3  2  4  6  1  1  1 
Subtotal  8  18  28  1  3  5  3  6  10  1  2  2 
PM2.5 
Mortality, ages < 1  117  455  891  93  457  972  83  322  630  64  314  666 
Mortality, ages 30+  19,531  100,976  175,452  -17,114  56,759  105,587  13,757  71,125  123,584  -11,850  39,303  73,114 
Chronic bronchitis, ages 18+  9,017  57,260  115,565  -2,198  9,520  19,400  6,137  38,969  78,649  -1,519  6,577  13,404 
Nonfatal heart attacks, ages 18+  3,282  24,344  43,855  3,850  19,147  33,559  2,328  17,262  31,097  2,651  13,184  23,108 
Respiratory hospital admissions  -923  1,719  3,078  428  1,691  3,911  -653  1,216  2,176  295  1,166  2,697 
Cardiovascular hosp. admissions, ages 18–64  233  599  1,097  364  558  864  165  425  779  251  384  595 
Cardiovascular hospital admissions, ages 65+  572  1,265  2,052  249  358  497  402  890  1,444  173  249  345 
Asthma emergency room visits, ages < 18  10  26  43  21  43  77  7  18  30  14  29  53 
Acute bronchitis in children, ages 8–12  -15  42  106  -4  61  169  -11  29  74  -3  43  118 
Upper resp. symptoms in children, ages 9–17  127  2,406  5,678  69  1,318  4,523  86  1,639  3,867  48  911  3,125 
Lower resp. symptoms in children, ages 7–14  98  317  642  25  109  265  66  216  437  17  76  184 
Asthma exacerbations, ages 6–18  201  934  1,778  128  342  703  137  636  1,211  89  238  488 
Work loss days, ages 18–64  4,041  4,545  5,192  3,842  4,440  5,450  2,868  3,225  3,684  2,644  3,055  3,750 
Minor restricted activity days, ages 18–64  17,193  34,626  60,330  3,933  9,632  14,619  11,706  23,576  41,078  2,707  6,629  10,062 
Subtotal  53,483  229,514  415,758  -6,314  104,433  190,595  37,079  159,549  288,740  -4,419  72,157  131,710 
  TOTAL  53,491  229,532  415,786  -6,312  104,437  190,600  37,082  159,555  288,751  -4,418  72,158  131,712 




We have used a suite of air quality, health impacts, and valuation models to 
analyze the effects on human morbidity and mortality of air pollution from the Intergen 
and Sempra power-exporting plants located just south of the California border. As 
discussed above, our analysis has limitations: our estimates of annual changes in air 
quality are extrapolated from model predictions for two 10-day episodes; confidence 
intervals for our health impacts and valuation results do not account for uncertainty in our 
air quality modeling; and we use U.S. CR and valuation functions for Mexico. That said, 
we find that Intergen and Sempra air emissions have limited but nontrivial health effects, 
mostly by exacerbating PM2.5 pollution in the United States. In total, the cost of the 
health damages is more than half a million dollars per year.     
Although we find that overall health effects from the plants are limited, our 
modeling clearly indicates that U.S.-owned power-exporting plants can have cross-border 
health effects in the United States. Of course, the magnitude of these cross-border effects 
depends on the specific characteristics of the plants (e.g., size, emissions characteristics, 
and abatement technologies) and of airsheds in which they are sited (e.g., demography 
and meteorology). In principle, these effects could be quite significant, a risk that makes 
systematic evaluation using the type of modeling strategies described in this paper 
advisable.  
Presumably, cross-border health effects could be largely avoided if the plants had 
mandates or incentives to reduce or offset their emissions. What policies could be used to 
achieve this end? Three broad approaches have been proposed (GAO 2005). One is to 
legally mandate that power-exporting plants meet U.S. emissions standards and offset 
requirements. This could be done either by enacting new federal or state legislation or by 
modifying DOE regulations for granting presidential permits to power-exporting plants 
for the use of cross-national transmission lines.  
A second, far more ambitious option is to develop a cross-border cap-and-trade 
system (Erickson et al. 2004; Johnson and Alvarez 2003). An aggregate cap on emissions 
in a national airshed would be negotiated and all sources in the airshed would be assigned 
permits that entitle them to quantities of emissions commensurate with the aggregate cap. 
Sources would be allowed to buy and sell permits, creating incentives for a cost-effective Resources for the Future  Blackman et al. 
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allocation of abatement across facilities.
7 Implementing such a program faces daunting 
challenges, however, including developing accurate emissions inventories covering all 
sources in the binational airshed; harmonizing U.S. and Mexican air pollution permitting; 
negotiating international agreements on aggregate caps, individual permit levels, and 
program rules; establishing a binational institution to administer the program; and 
coordinating monitoring and enforcement. Given these requisites, it is perhaps not 
surprising that this approach has yet to be piloted.
8  
A third option is to establish a binational trust fund to identify, prioritize, and fund 
specific air quality management projects (Ryan et al. 2008; GNEB 2010). Funding could 
be derived from, for example, direct appropriations from U.S. and Mexican legislatures, 
fees charged to cross-border commuters, or taxes on large emissions sources, such as 
power plants. International coordination would be required to collect and administer the 
trust fund. Advocates have argued that the fund could be housed within the bilateral 
institutions created by the environmental side agreements to the North American Free 
Trade Agreements, specifically the North American Development Bank, which finances 
environmental infrastructure projects, and the Border Environmental Cooperation 
Commission, which assists local communities in developing environmental 
infrastructure. Questions have been raised about the efficiency and responsiveness of 
both institutions, however (Ryan et al. 2008).   
Of those three options, the first—regulatory mandates for air pollution control for 
power-exporting plants—is almost certainly the most feasible. Unlike the other two 
options, it requires no international coordination and very little institution building. 
Indeed, as noted in the introduction, in September 2010, one border state, California, 
passed legislation (Senate bill 2037) that requires new electricity-generating units in 
Mexico that sell power to the state to comply with all the air pollution control 
regulations—including best available control technology standards and offset 
requirements—applicable in the California air basin adjacent to the facility. The bill does 
not apply retroactively to the Intergen and Sempra plants in Mexicali, only to new 
                                                 
7 Facilities with low abatement costs would have incentives to cut their emissions and sell their excess 
permits to plants with higher abatement costs. Therefore, the burden of abatement would be shifted from 
high abatement cost plants to low abatement cost plants (Sterner 2003). 
8 A less ambitious baseline-and-trade program has been piloted in Texas. The program allows Texas 
facilities on the U.S.–Mexico border to meet their pollution reduction mandates by purchasing offsets from 
sources in Mexico with which they share an airshed (Erickson et al. 2004).  Resources for the Future  Blackman et al. 
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facilities built after January 1, 2011, and to additional capacity installed at existing 
facilities after that date.  
California’s legislation has not resolved the problem of transborder pollution from 
Mexican power-exporting plants, however. It remains to be seen whether the three other 
U.S. border states will follow California’s lead. Also, given that lower permitting, capital, 
and labor costs in Mexico—not lower environmental regulatory costs—appear to have 
driven Intergen’s and Sempra’s decisions to build there, it is reasonable to expect more 
power-exporting plants to be built if energy supply in the border region falls short of 
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Appendix 1. Method Used to Convert Concentrations of NOx, NH3, and CO (in 
ppm) to Annual Mass Emissions Rate (in short tons/yr) for Intergen and Sempra 
Plants 
For three pollutants—NOx, NH3, and CO—we estimated the annual mass emissions rate from 
data on stack gas concentrations from GAO (2005)  along with information on fuel consumption 
from DOE (2004). We used this method because data on exhaust flow rates, which are often used 
to estimate mass emissions rates, are not available. We used the following formula 
 
MER = GC×ERTS/2000 
 
ERTS = CON×CF×MW×(1/SMV)×10^(-6)×FD  
 
where the parameters (along with units and sources) are defined in Table A1.  
Table A1. Parameters Used to Convert NOx, NH3, and CO Concentrations to Annual Mass 
Emissions for Intergen and Sempra Plants 




Value for  
CO 
Source 
CF  Conversion factor: 15% O2 
























b  GAO (2005) p. 13, 
Table 2 
ERTS  Emissions rate of thermal system  lbs/MMBtu  —  —  —  calculated 
FD  Dry oxygen F-factor for natural 
gas 
dscf/MMBtu  8710 at 68°F  8710 at 68°F  8710 at 68°F  40 C.F. R. Part 60 
Appendix A 2.1, or 
EPA Method 19, page 
1144, Table 19-2 
GC  
(Sempra) 
























Appendix G, Table G-
1  
MER  Mass emissions rate  Short tons/yr  —  —  —  Calculated 
MW  Molecular weight  u  46  17  28   







aAverage for turbines 1 and 2. 
bAverage for turbines 1-4. Resources for the Future  Blackman et al. 
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Appendix 2. Tracking Analysis Framework (TAF) Health Impacts and Valuation 
Models 
As noted in Sections 7 and 8,, many of the concentration-response (CR) and valuation 
distributions in the TAF model are actually weighted averages of several distributions reported in 
the literature. Drawn from Lankton (2006), this appendix provides information on these 
distributions. For the health effects model, this information includes the originating study, the 
time period used to measure the pollutant, the CR functional form, the mean and standard 
deviation of the distribution, what other pollutants were included in the study, and the weight 
assigned to each study if multiple studies were used to generate a weighted average distribution 
for a single health endpoint. For the valuation module, this information includes the originating 
study and the valuation function. Note that the weights we use are the default weights in the TAF 
model. They approximate the weights that EPA used when pooling both CR and (separately) 
valuation studies in its analysis of the proposed Interstate Air Quality Rule and Nonroad Diesel 
Rule. 
A2.1. Ozone 
For each of the five ozone-related health effects, the concentration-response and 
valuation studies are summarized in Tables A2 and A3.  
Respiratory Hospital Admissions  
Respiratory hospital admissions (RHAs), in number of incidences per season, are 
calculated for two age groups: 65 and over, and under 2. The CR functions used are aggregated 
across three RHA subcategories: asthma, chronic lung disease, and pneumonia.  
RHA valuation is calculated separately for each age group. However, the only difference 
between the two age-group studies is the parameter for mean length of hospital stay. CPI Med 
and ECI Wage are price indices from BenMap. 
Asthma Emergency Room Visits 
Asthma emergency room visits (AERVs), in number of incidences per season, are 
calculated for all ages (aggregate). The AERV CR functions in the TAF model are based on five-
hour average ozone concentrations, for which eight-hour average ozone concentrations are 
substituted. This results in a lower-bound estimate of AERV incidences and valuation. Resources for the Future  Blackman et al. 
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AERV valuation is calculated for all ages (aggregate). ECI Wage is a price index from 
BenMap. There are two valuation studies for AERV (these valuation studies are also used to 
value AERVs due to PM2.5 exposure): 
School Absence Days 
School absence days (SADs), in number of incidences per season, are estimated for the 
age group 5 to 17 (inclusive). The SAD CR functions used are Gilliland et al. (2001) for ages 9 
to 10 and Chen et al. (2000) for ages 6 to 11. TAF applies a weighted average of these studies to 
the population age group 5 to 17. The SAD baseline incidence rates are from a 1996 National 
Center for Educational Statistics study. 
There is one SAD valuation study in TAF. Each SAD is valued at $75 and adjusted by 
ECI Wage, a price index from BenMap. 
 
Minor Restricted Activity Days 
Minor restricted activity day (MRAD) incidences are calculated by season for the age 
group 18 to 64 (inclusive). Baseline incidence rates for MRADs are from Ostro and Rothschild 
(1989). 
For the purposes of valuation, the model treats minor respiratory restricted activity days 
(MRRADs) and MRADs interchangeably because no studies have determined willingness to pay 
to avoid MRADs (see BenMap documentation, page H-16). The MRAD valuation study in TAF 
is Industrial Economics Incorporated (IEc 1993), a contingent valuation study for willingness to 
pay of an adult to avoid a three-symptom day of coughing, throat congestion, and sinusitis. This 
study is also used when estimating the value of MRAD incidences related to PM2.5 exposure. 
Short-term Mortality 
Ozone-related short-term mortality (STM) incidences are calculated by season for all 
ages (aggregate). Baseline incidence rates are from BenMap. 
Valuation for short-term mortality related to ozone exposure is estimated using the value 
of a statistical life. 
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Respiratory hospital admissions (RHAs)  
Age 65+ 
       
Schwartz (1995)  24 hours 
(New Haven) 
Log-linear 
0.002652 (0. 001398) 
PM10  0.50 
Schwartz (1995)  24 hours 
(Takoma) 
 Log-linear 
0.007147 (0. 002565) 
PM10  0.50 
Respiratory hospital admissions (RHAs)  
Age < 2 
       
Burnett et al. (2001)  1 hour 
(Toronto) 
Log-linear 
0.006309 (0. 001834) 
PM2.5  1.00 
Asthma emergency room visits (AREVs) 
All ages 
       




None  0.49 




SO2  0.51 
Short-term mortality (STM) 
All ages 
       





PM10  1.00 
 
Table A3. Ozone Health Effects Valuation Methods in TAF Model 
Health endpoint 
Study (year) 
Valuation function  Weight 
Respiratory hospital admissions (RHAs)  
Age 65+ 
   
Abt Associates (2003); Agency for 
Healthcare Research and Quality (2000) 
Incidences × CPI Med + B × I × ECI Wage 
B = 6.882932 = Mean length of hospital stay in 
days 




Respiratory hospital admissions (RHAs)  
Age < 2 
   
Abt Associates (2003); Agency for 
Healthcare Research and Quality (2000) 
Incidences × CPI Med + B × I × ECI Wage 
B = 2. 974239 = Mean length of hospital stay in 
days 




Asthma emergency room visits (AREVs) 
All ages 
   
Smith et al. (1997)  Incidences × Distribution 
Distribution is triangular, adjusted by ECI wage 
(min 230.7, mode 311.6, max 430.9, year 2000$) 
0.50 
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Stanford et al. (1999)  Incidences × Distribution 
Distribution is normal, adjusted by ECI wage 
(mean 260.7, sd 5.225, year 2000$) 
0.50 
 
Short-term mortality (STM) 
All ages 
   
Mrozek and Taylor (2002) (all ages)  •  Incidences × (Value of a statistical life) 






For each of the 12 PM2.5-related health effects, the concentration-response and valuation 
studies are summarized in Tables A4 and A5.  
Mortality 
PM2.5 mortality incidences are estimated annually for two age groups: under 1, and 30 
and over. Baseline incidence rates are from BenMap. 
Valuation for mortality related to PM2.5 exposure is estimated using the value of a 
statistical life. 
Chronic Bronchitis 
Chronic bronchitis (CB) incidences are estimated annually for the age group 27 and over. 
Baseline incidence and prevalence rates are from BenMap. 
There are three valuation studies for chronic bronchitis. All three are from the BenMap 
model, and no specific studies are cited. The two cost-of-illness studies, one with a 3 percent 
discount rate and one with a 7 percent discount rate, are weighted by age within the 27-and-over 
age group. The other study is based on willingness to pay to avoid a case of pollution-related 
chronic bronchitis; this valuation does not vary within the 27-and-over age group. 
Nonfatal Heart Attacks 
Nonfatal heart attack (NFHA) incidences are estimated seasonally for the age group 18 
and over. Baseline incidence rates are from BenMap. 
There are two NFHA valuation studies in TAF, both from BenMap with no specific study 
cited: one with a 3 percent discount rate, and one with a 7 percent discount rate. Both studies 
incorporate 10 years of medical costs and 5 years of wage costs. 
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Respiratory Hospital Admissions 
Respiratory hospital admission (RHA) incidences related to PM2.5 exposure are 
estimated seasonally for all ages. Baseline incidence rates are from BenMap. 
There is a single RHA valuation study in TAF for RHA incidences related to PM2.5 
exposure. 
Cardiovascular Hospital Admissions 
Cardiovascular hospital admission (CHA) incidences are estimated seasonally for two 
age groups: 18 to 64 (inclusive), and 65 and over. There are four studies for the 18-to-64 age 
group. The Moolgavkar (2003) study aggregates all cardiovascular symptoms. The Ito (2003) 
studies are separated by symptom: ischemic, dysrhythmia, and heart failure. Moolgavkar (2003) 
uses an aggregate baseline incidence rate; the Ito studies use incidence rates specific to each 
symptom. All incidence rates are from BenMap. There is a single study for the 65-and-over age 
group, aggregate for all cardiovascular symptoms. 
The CHA valuation parameters for mean hospital charge and mean length of stay differ 
between the 1-to-64 and 65-and-overage group. 
Asthma Emergency Room Visits 
Asthma emergency room visit (AERV) incidences related to PM2.5 exposure are 
estimated seasonally for the age group under 18. Baseline incidence rates  
There are two valuation studies for AERVs. These valuation studies are shared with 
AERV incidences due to ozone exposure. 
Acute Bronchitis in Children 
Acute bronchitis in children (ABiC) incidences are estimated annually for the age group 
8 to 12 (inclusive). Baseline incidence rates are from BenMap. 
The valuation study for ABiC is a six-day illness study. 
Upper Respiratory Symptoms in Children 
Upper respiratory symptoms in children (URSiC) incidences are estimated seasonally for 
the age group 9 to 17 (inclusive). Baseline incidence and prevalence rates are from BenMap. 
The URSiC valuation study is a two-symptom, one-day study from BenMap. 
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Lower Respiratory Symptoms in Children 
Lower respiratory symptoms in children (LRSiC) incidences are estimated seasonally for 
the age group 7 to 14. Baseline incidence rates are from BenMap. 
The LRSiC valuation study is a two-symptom, one-day study from BenMap. 
Asthma Exacerbations 
Asthma exacerbation (AE) incidences are estimated seasonally for the age group 5 to 17 
(inclusive). These incidences are estimated by symptom and then aggregated for total AE 
incidences. Baseline incidence rates are from BenMap. 
Three valuation studies for AE exist in TAF: one symptom day, one bad asthma day, and 
two bad asthma days. The default TAF valuation study is the one bad asthma day study. 
Work Loss Days 
Work loss day (WLD) incidences are estimated seasonally for the age group 18 to 64 
(inclusive). Baseline incidence rates are from BenMap. 
WLD valuation is estimated by adjusting median income by the wage price index from 
BenMap. 
Minor Restricted Activity Days 
Minor restricted activity day (MRAD) incidences are estimated seasonally for the age 
group 18 to 64 (inclusive). Baseline incidence rates are from BenMap. 
For the purposes of valuation, the model treats minor respiratory restricted activity days 
(MRRADs) and MRADs interchangeably because no studies have determined willingness to pay 
to avoid MRADs (see BenMap documentation, H-16). The MRAD valuation study, Industrial 
Economics Incorporated (1993), is a contingent valuation study for an adult’s willingness to pay 
to avoid a three-symptom day of coughing, throat congestion, and sinusitis. These valuation 
studies are also used when estimating the value of MRAD incidences related to ozone exposure. 
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None  1.00 
Mortality 
Age 30+ 
       




None  1.00 
Chronic bronchitis (CB)  
Age 27 + 
       
Abbey et al. (1995)  Annual average 




None  1.00 
Nonfatal heart attacks (NFHAs) 
Age 18+ 
       




None  1.00 
Respiratory hospital admissions (RHA) 
All ages 
       




O3  1.00 
Cardiovascular hosp. admissions (CHA) 
Age 18–64 
       


















None  0.007 






None  0.007 
Cardiovascular hosp. admissions (CHA) 
Age 65+ 
       




None  1.00 
Asthma emergency room visits (AERV)  
All ages 
       




None  1.00 
Acute bronchitis in children (ABiC)  
Age 8–12 
       




None  1.00 
Upper resp. symp. in children (URSiC)  
Age 9–17 
       




None  1.00 
Lower resp. symp. in children (LRSiC) 
Age 7–14 
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None  1.00 
Asthma exacerbation (AE)  
Age 5–17 
       






None  0.37 






None  0.24 






None  0.38 
Work loss days (WLDs)  
Age 18–64 
       




None  1.00 
Minor restricted activity days (MRADs)  
Age 18–64 
       




None  1.00 
 
 
Table A5. PM2.5 Health Effects Valuation Methods in TAF Model 
Health endpoint 
Study (year) 
Valuation function  Weight 
Mortality 
Age <1 
   
All ages 
Mrozek and Taylor (2002)   •  Incidences × (Value of a statistical life) 






   
All ages 
Mrozek and Taylor (2002)   •  Incidences × (Value of a statistical life) 




Chronic bronchitis (CB)  
Age 27 + 
   
WTP average severity 
Abt Associates (2003); Krupnick and 
Cropper (1992); Viscusi et al. (1991) 
A × CPI 
Adjusted by CPI 
(A = 340481.843750 = WTP to avoid a case of 
pollution related chronic bronchitis, year 2000$) 
1.00 
 
     
Nonfatal heart attacks (NFHAs) 
Age 18+ 
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COI 3% discount rate 
Cropper and Krupnick (1990) 
A × CPI_Med + B × ECI_Wage 
Adjusted by CPI and ECI wage 
 
A = PDV of medical costs, 3% discount 
B = PDV of opportunity costs, 3% discount 
 
Parameter values vary by age group: 
18–24: (A = 49650.941406, B = 0.00) 
25–44: (A = 49650.941406, B = 9032.534180) 
45–54: (A = 49650.941406, B = 13313.006836) 
55–64: (A = 49650.941406, B = 76950.710938) 
65 and over: (A = 49650.941406, B = 0.00) 
1.00 
Respiratory hospital admissions (RHAs) 
All ages 
   
Abt Associates (2003); Agency for 
Healthcare Research and Quality (2000) 
A × CPI_Med + B × I × ECI_Wage 
Adjusted by CPI and ECI wage 
 
A = 14999.00 = Mean hospital charge 
B = 5.630323 = Mean length of hospital stay 
I = Median income 
1.00 
Cardiovascular hosp. admissions (CHAs) 
Age 18–64 
   
Abt Associates (2003); Agency for 
Healthcare Research and Quality (2000) 
A × CPI_Med + B × I × ECI_Wage 
Adjusted by CPI and ECI wage 
 
A = 22300.00 = Mean hospital charge 
B = 4.150256 = Mean length of hospital stay 
(days) 
I = Median income 
1.00 
Asthma emergency room visits (AERVs)  
Age < 18 
   
Smith et al. (1997)  Distribution × CPI Med 
Distribution is triangular, adjusted by CPI med 
(mode 311.6, min 230.7, max 430.9, $ year 2000) 
0.50 
Stanford et al. (1999)  Distribution × CPI Med 
Distribution is mormal, adjusted by CPI med 
(mean 260.7, sd 5.225, year 2000$) 
0.50 
Acute bronchitis in children (ABiC)  
Ages 8–12 
   
6-day illness 
Abt Associates (2003); IEc (1994) 
Distribution × CPI 
Distribution is uniform, adjusted by CPI 
(mean 355.849243, min 105.059128, max 
606.639404, year 2000$) 
1.00 
Upper resp. symp. in children (URSiC)  
Ages 9–17 
   
2 symptoms, 1 day 
Abt Associates (2003); IEc (1993) 
Distribution × B × CPI 
Distribution is uniform, adjusted by CPI 
B = 2.00 = Adjustment of WTP from adult to child 
(mean 24. 637644, min 9.222648, 43.109287, year 
2000$) 
1.00 
Lower resp. symp. in children (LRSiC) 
Ages 7–14 
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2 symptoms, 1 day 
Abt Associates (2003); IEc (1993) 
Distribution × B × CPI 
Distribution is uniform, adjusted by CPI 
B = 2.00 = Adjustment of WTP from adult to child 
(mean 15.573099, min 6.943336, max 24.466366, 
year 2000$) 
1.00 
Asthma exacerbation (AE)  
Ages 5–17 
   
2 bad asthma days 
Abt Associates (2003); Rowe and Chestnut 
(1986) 
Distribution × CPI 
Distribution is uniform, adjusted by CPI 
 (mean 42.793083, min 15.559923, max 
70.882629, $ year 2000) 
1.00 
Work loss days (WLDs)  
Ages 18–64 
   
Abt Associates (2003)  I × ECI Wage 
I = Median income 
Adjusted by ECI wage 
1.00 
Minor restricted activity days (MRADs)  
Ages 18–64 
   
Abt Associates (2003); IEc (1993)  Distribution × CPI 
Distribution is triangular, adjusted by CPI 
(mean 50.55, min 20.71, max 80.37, year 2000$) 
1.00 
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